Category: BioPartner 2

  • Clear

INFECTA

INFECTA is a clinical research organization focused on accelerating the development of infectious disease products through early-phase clinical testing. INFECTA’s approach centers on efficient clinical trials using smart study design,

Read More »

Mireca Medicines GmbH

Mireca Medicines GmbH is an expanding, preclinical stage company pioneering the development of proprietary cyclic guanosine monophosphate (cGMP)-analogs and drug delivery technologies to treat diseases caused by a dysregulation of

Read More »

Orfenix

Orfenix is a venture builder that creates and manages projects to move an idea from the lab to market authorisation by creating and augmenting teams with relevant expertise around key

Read More »

CML

The Institute of Environmental Sciences (CML) at Leiden University is at the forefront of industrial ecology, environmental biology, and sustainability science. We aim to remain a global leader in sustainability

Read More »

Omivera

Assess true kinase selectivity in living cells. Measuring drug selectivity where it truly matters. We provide definitive, in-cell target engagement and selectivity data to de-risk and accelerate your drug discovery pipeline.

Read More »